Hey Kutz... Since you are working late anyway... lol... Cramer is pumping this as a double possibility... says it has good cardio drugs... One approved, and another potentially on the way... also called it a potential take-over target...  Price was around $11.30 when he started blabbing about it...

 

Approved:

Ranexa (ranolazine extended-release tablets), which was approved in the United States, in January 2006, for the treatment of chronic angina...

 

Pending:

 Regadenoson, a selective A2A-adenosine receptor agonist, for use as a pharmacologic agent in myocardial perfusion imaging studies.   (Huh?   Does this mean taking pictures of the heart?... Lol... )